Drug Shortage Report for TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION
| Report ID | 1659 |
| Drug Identification Number | 02412063 |
| Brand name | TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION |
| Common or Proper name | TRAVAPROST |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | TRAVOPROST |
| Strength(s) | 0.004% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | 2.5ML |
| ATC code | S01EE |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2016-02-29 |
| Estimated end date | |
| Actual end date | 2019-11-30 |
| Shortage status | Resolved |
| Updated date | 2020-01-21 |
| Company comments | Item is discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-01-21 | French | Compare |
| v5 | 2020-01-21 | English | Compare |
| v4 | 2017-10-10 | French | Compare |
| v3 | 2017-10-10 | English | Compare |
| v2 | 2017-03-13 | French | Compare |
| v1 | 2017-03-13 | English | Compare |
Showing 1 to 6 of 6